Literature DB >> 22085995

2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features.

Grace J Noh1, John M Graham.   

Abstract

We report a 2-year-old female who initially presented with seizures, developmental delay and dysmorphic features and was found to have a 0.3 Mb deletion at chromosome 2q23.1 encompassing the critical seizure gene, MBD5. Her distinct physical features include bifrontal narrowing with brachycephaly, low anterior hairline, hypotonic facial features with short upturned nose, flat nasal bridge, hypertelorism, tented upper lip with everted lower lip, downturned corners of her mouth, and relatively coarse facial features including thickened tongue. She also had a short neck, brachytelephalangy, clinodactyly, and hypertrichosis. At 3½ years she developed progressive ataxia and lost vocabulary at the age of 4. Regression has been reported in one other case of MBD5 deletion. MBD5 is a member of the methyl binding gene family and appears to be responsible for regulating DNA methylation in the central nervous system. Our patient was entirely deleted for the MBD5 gene with partial loss of the EPC2 gene, which suggests that haploinsufficiency of MBD5 is responsible for the distinct phenotype observed. This supports the hypothesis that MBD5 is indeed the critical gene implicated for the findings seen in patients with deletions of chromosome 2q23.1. Further studies are necessary to delineate the role that the MBD5 gene plays in the development of the brain and these specific physical characteristics.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085995     DOI: 10.1016/j.ejmg.2011.10.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.

Authors:  Holly N Cukier; Joycelyn M Lee; Deqiong Ma; Juan I Young; Vera Mayo; Brittany L Butler; Sandhya S Ramsook; Joseph A Rantus; Alexander J Abrams; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Jonathan L Haines; Michael L Cuccaro; Margaret A Pericak-Vance; John R Gilbert
Journal:  Autism Res       Date:  2012-10-10       Impact factor: 5.216

Review 2.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

3.  MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.

Authors:  Sureni V Mullegama; Loren Pugliesi; Brooke Burns; Zalak Shah; Raiha Tahir; Yanghong Gu; David L Nelson; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2014-10-01       Impact factor: 4.246

4.  Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.

Authors:  J C Hodge; E Mitchell; V Pillalamarri; T L Toler; F Bartel; H M Kearney; Y S Zou; W H Tan; C Hanscom; S Kirmani; R R Hanson; S A Skinner; R C Rogers; D B Everman; E Boyd; C Tapp; S V Mullegama; D Keelean-Fuller; C M Powell; S H Elsea; C C Morton; J F Gusella; B DuPont; A Chaubey; A E Lin; M E Talkowski
Journal:  Mol Psychiatry       Date:  2013-04-16       Impact factor: 15.992

Review 5.  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

Authors:  Sureni V Mullegama; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

6.  The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease.

Authors:  Dorothy Warburton; Michael Ronemus; Jennie Kline; Vaidehi Jobanputra; Ismee Williams; Kwame Anyane-Yeboa; Wendy Chung; Lan Yu; Nancy Wong; Danielle Awad; Chih-Yu Yu; Anthony Leotta; Jude Kendall; Boris Yamrom; Yoon-Ha Lee; Michael Wigler; Dan Levy
Journal:  Hum Genet       Date:  2013-08-25       Impact factor: 4.132

7.  Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.

Authors:  Sureni V Mullegama; Joseph T Alaimo; Li Chen; Sarah H Elsea
Journal:  Int J Mol Sci       Date:  2015-04-07       Impact factor: 5.923

8.  A novel MBD5 mutation in an intellectually disabled adult female patient with epilepsy: Suggestive of early onset dementia?

Authors:  Willem Verhoeven; Jos Egger; Janneke Kipp; Jiska Verheul-Aan de Wiel; Charlotte Ockeloen; Tjitske Kleefstra; Rolph Pfundt
Journal:  Mol Genet Genomic Med       Date:  2019-07-09       Impact factor: 2.183

Review 9.  A novel interstitial deletion of chromosome 2q21.1-q23.3: Case report and literature review.

Authors:  Bader Almuzzaini; Nasser S Alatwi; Saif Alsaif; Mohammed A Al Balwi
Journal:  Mol Genet Genomic Med       Date:  2020-01-28       Impact factor: 2.183

10.  Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy.

Authors:  Andrew E Fry; Elliott Rees; Rose Thompson; Kiran Mantripragada; Penny Blake; Glyn Jones; Sian Morgan; Sian Jose; Hood Mugalaasi; Hayley Archer; Emma McCann; Angus Clarke; Clare Taylor; Sally Davies; Frances Gibbon; Johann Te Water Naude; Louise Hartley; Gareth Thomas; Catharine White; Jaya Natarajan; Rhys H Thomas; Cheney Drew; Seo-Kyung Chung; Mark I Rees; Peter Holmans; Michael J Owen; George Kirov; Daniela T Pilz; Michael P Kerr
Journal:  BMC Med Genet       Date:  2016-04-26       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.